ERBB2 and breast carcinoma: We recently used single-cell RNA-sequencing of an aggressive Her2+ breast cancer GEMM (Turpin et al, 2016; Zhang et al, 2021b) to identify the genes altered during tumor immunoediting (Zhang et al, 2024).